1Knekt, P, Kumpulainen, J, Jarvinen, R, et al. (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76, 560–568.
2Justesen, U, Knuthsen, P & Leth, T (1997) Determination of plant polyphenols in Danish foodstuffs by HPLC–UV and LC–MS detection. Cancer Lett 114, 165–167.
3Garg, A, Garg, S, Zaneveld, LJ, et al. (2001) Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 15, 655–669.
4Chiba, H, Uehara, M, Wu, J, et al. (2003) Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr 133, 1892–1897.
5Aranganathan, S, Selvam, JP & Nalini, N (2008) Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen-induced aberrant crypt foci in colon cancer rats: a dose-dependent study. J Pharm Pharmacol 60, 1385–1392.
6Benavente-Garcia, O & Castillo, J (2008) Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 56, 6185–6205.
7Kim, JY, Jung, KJ, Choi, JS, et al. (2006) Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin. Aging Cell 5, 401–411.
8Tomas-Barberen, FA & Clifford, MN (2000) Flavanones, chalcones and dihydrochalcones – nature, occurrence and dietary burden. J Sci Food Agric 80, 1073–1080.
9Nielsen, IL, Chee, WS, Poulsen, L, et al. (2006) Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial. J Nutr 136, 404–408.
10Hollman, PC, Bijsman, MN, van Gameren, Y, et al. (1999) The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res 31, 569–573.
11Manach, C, Morand, C, Gil-Izquierdo, A, et al. (2003) Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr 57, 235–242.
12Day, AJ, Canada, FJ, Diaz, JC, et al. (2000) Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 468, 166–170.
13Sesink, AL, Arts, IC, Faassen-Peters, M, et al. (2003) Intestinal uptake of quercetin-3-glucoside in rats involves hydrolysis by lactase phlorizin hydrolase. J Nutr 133, 773–776.
14Day, AJ, DuPont, MS, Ridley, S, et al. (1998) Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity. FEBS Lett 436, 71–75.
15Nemeth, K, Plumb, GW, Berrin, JG, et al. (2003) Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 42, 29–42.
16Brand, W, van der Wel, PA, Rein, MJ, et al. (2008) Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metab Dispos 36, 1794–1802.
17Poquet, L, Clifford, MN & Williamson, G (2008) Transport and metabolism of ferulic acid through the colonic epithelium. Drug Metab Dispos 36, 190–197.
18Breinholt, VM, Svendsen, GW, Dragsted, LO, et al. (2004) The citrus-derived flavonoid naringenin exerts uterotrophic effects in female mice at human relevant doses. Basic Clin Pharmacol Toxicol 94, 30–36.
19Nielsen, SE & Sandstrom, B (2003) Simultaneous determination of hydroxycinnamates and catechins in human urine samples by column switching liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 787, 369–379.
20Xie, MX, Xu, XY & Wang, YD (2005) Interaction between hesperetin and human serum albumin revealed by spectroscopic methods. Biochim Biophys Acta 1724, 215–224.
21Felgines, C, Texier, O, Morand, C, et al. (2000) Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol Gastrointest Liver Physiol 279, G1148–G1154.
22Kanaze, FI, Bounartzi, MI, Georgarakis, M, et al. (2007) Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr 61, 472–477.
23Habauzit, V, Nielsen, IL, Gil-Izquierdo, A, et al. (2009) Increased bioavailability of hesperetin-7-glucoside compared with hesperidin results in more efficient prevention of bone loss in adult ovariectomised rats. Br J Nutr 102, 976–984.
24Erlund, I, Meririnne, E, Alfthan, G, et al. (2001) Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 131, 235–241.
25Mullen, W, Archeveque, MA, Edwards, CA, et al. (2008) Bioavailability and metabolism of orange juice flavanones in humans: impact of a full-fat yogurt. J Agric Food Chem 56, 11157–11164.
26Day, AJ, Gee, JM, DuPont, MS, et al. (2003) Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem Pharmacol 65, 1199–1206.
27Brett, GM, Hollands, W, Needs, PW, et al. (2008) Absorption, metabolism and excretion of flavanones from single portions of orange fruit and juice and effects of anthropometric variables and contraceptive pill use on flavanone excretion. Br J Nutr 101, 1–12.
28Matsumoto, H, Ikoma, Y, Sugiura, M, et al. (2004) Identification and quantification of the conjugated metabolites derived from orally administered hesperidin in rat plasma. J Agric Food Chem 52, 6653–6659.
29Yamada, M, Tanabe, F, Arai, N, et al. (2006) Bioavailability of glucosyl hesperidin in rats. Biosci Biotechnol Biochem 70, 1386–1394.
30Mullen, W, Edwards, CA & Crozier, A (2006) Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr 96, 107–116.
31O'Leary, KA, Day, AJ, Needs, PW, et al. (2003) Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human β-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 65, 479–491.
32Jaganath, IB, Mullen, W, Edwards, CA, et al. (2006) The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man. Free Radic Res 40, 1035–1046.
33Day, AJ, Mellon, FA, Barron, D, et al. (2001) Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 212, 941–952.
34Silberberg, M, Morand, C, Mathevon, T, et al. (2006) The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites. Eur J Nutr 45, 88–96.
35Scalbert, A & Williamson, G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130, 2073S–2085S.
36Strassburg, CP, Nguyen, N, Manns, MP, et al. (1999) UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology 116, 149–160.
37Glatt, H, Engelke, CE, Pabel, U, et al. (2000) Sulfotransferases: genetics and role in toxicology. Toxicol Lett , 341–348.
38Williamson, G, Barron, D, Shimoi, K, et al. (2005) In vitro biological properties of flavonoid conjugates found in vivo. Free Radic Res 39, 457–469.
39Proteggente, AR, Basu-Modak, S, Kuhnle, G, et al. (2003) Hesperetin glucuronide, a photoprotective agent arising from flavonoid metabolism in human skin fibroblasts. Photochem Photobiol 78, 256–261.
40Manach, C, Morand, C, Crespy, V, et al. (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426, 331–336.
41Day, AJ, Bao, Y, Morgan, MRA, et al. (2000) Conjugation position of quercetin glucuronides and effect on biological activity. Free Rad Biol Med 29, 1234–1243.
42Vauzour, D, Vafeiadou, K, Rice-Evans, C, et al. (2007) Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem 103, 1355–1367.